Cargando…
Identification of Prognostic Markers in Cholangiocarcinoma Using Altered DNA Methylation and Gene Expression Profiles
BACKGROUND: Cholangiocarcinoma (CCA) is a rare disease, but it is amongst the most lethal cancers with a median survival under 1 year. Variations in DNA methylation and gene expression have been extensively studied in other cancers for their role in pathogenesis and disease prognosis, but these stud...
Autores principales: | Mishra, Nitish Kumar, Niu, Meng, Southekal, Siddesh, Bajpai, Prachi, Elkholy, Amr, Manne, Upender, Guda, Chittibabu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606733/ https://www.ncbi.nlm.nih.gov/pubmed/33193605 http://dx.doi.org/10.3389/fgene.2020.522125 |
Ejemplares similares
-
Molecular Subtyping and Survival Analysis of Osteosarcoma Reveals Prognostic Biomarkers and Key Canonical Pathways
por: Southekal, Siddesh, et al.
Publicado: (2023) -
Survival Analysis of Multi-Omics Data Identifies Potential Prognostic Markers of Pancreatic Ductal Adenocarcinoma
por: Mishra, Nitish Kumar, et al.
Publicado: (2019) -
Prognostic value of biomarkers in the tumor microenvironment of pancreatic ductal adenocarcinoma
por: Mishra, Nitish K., et al.
Publicado: (2020) -
Pan-Cancer Analysis of Human Kinome Gene Expression and Promoter DNA Methylation Identifies Dark Kinase Biomarkers in Multiple Cancers
por: Southekal, Siddesh, et al.
Publicado: (2021) -
mintRULS: Prediction of miRNA–mRNA Target Site Interactions Using Regularized Least Square Method
por: Shakyawar, Sushil, et al.
Publicado: (2022)